Carelane uses digital health technology to reduce inefficiencies in clinical trials.
Carelane has raised $863K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2023.
Carelane's investors include HTGF (High-Tech Gruenderfonds).
Carelane is headquartered in Bremen, Germany.
Carelane uses digital health technology to reduce inefficiencies in clinical trials.
Carelane is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Carelane — Funding & Investors." VCBacked, September 1, 2023, https://www.vcbacked.co/company/carelane. Accessed August 2, 2026.
VCBacked. (2023). Carelane — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/carelane
{{cite web |title=Carelane — Funding & Investors |url=https://www.vcbacked.co/company/carelane |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated